latest news releases from the newsroom
Epilepsy Seizures Drop 50% in Cannabidiol Study
VANCOUVER, British Columbia, Nov. 24, 2014 (GLOBE NEWSWIRE) -- A new study from Orrin Devinsky, MD, of the New York University School of Medicine, suggests that Cannabidiol (CBD) may radically reduce seizures in patients with epilepsy.
Receptos Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Completion of Underwritten Public Offering of Common Stock
SAN DIEGO, Nov. 24, 2014 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, announced today the completion of the previously announced underwritten public offering of an aggregate of 4,140,000 shares of its common stock at a price to the public of $100.00 per share, which included 540,000 shares of its common stock sold pursuant to the full exercise of the option to purchase additional shares previously granted to the underwriters. The aggregate gross proceeds to Receptos from this offering were $414.0 million, before deducting underwriting discounts and commissions and other estimated offering expenses. All of the shares of common stock in the offering were sold by Receptos.
DANSKE BANK A/S:N LIIKKEESEEN LASKEMAN TKNE4X 40DAN TURBOWARRANTIN MARKKINATAKAUS ON PÄÄTTYNYT
DANSKE BANK A/S PÖRSSITIEDOTE
DANSKE BANK A/S:N LIIKKEESEEN LASKEMAN TKNE4X 40DAN TURBOWARRANTIN
MARKKINATAKAUS ON PÄÄTTYNYT
Danske Bank A/S:n liikkeeseen laskeman TKNE4X 40DAN turbowarrantin
markkinatakaus on päättynyt kohde-etuuden hinnan saavutettua turbowarrantin
rajatason (Barrier Level). Kyseisen turbowarrantin juoksuaika ja kaupankäynti
päättyivät 24.11.2014 kello 16:41.
Markkinatakauksen päättyminen koskee seuraavaa turbowarranttia:
Liikkeeseenlaskija: Danske Bank A